{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:17:03Z","timestamp":1771039023892,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Liver Disease"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1002\/cld.604","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T06:38:12Z","timestamp":1484289492000},"page":"160-166","source":"Crossref","is-referenced-by-count":12,"title":["Mechanisms of portal hypertension: Bench to bedside"],"prefix":"10.1097","volume":"8","author":[{"given":"Jordi","family":"Gracia\u2010Sancho","sequence":"first","affiliation":[{"name":"Barcelona Hepatic Hemodynamic Laboratory,Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Institute and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD),Barcelona,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Laleman","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Section of Liver and Biliopancreatic Disorders, University Hospitals Leuven,KU Leuven,Leuven,Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"issue":"1 Suppl","key":"cld604-bib-0001-20240115","first-page":"S121","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in the paradigm are leading to successful new treatments","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"cld604-bib-0002-20240115","first-page":"183","article-title":"New cellular and molecular targets for the treatment of portal hypertension","volume":"2","year":"2015","journal-title":"Hepatol Int"},{"key":"cld604-bib-0003-20240115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","article-title":"Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis","volume":"126","year":"2004","journal-title":"Gastroenterology"},{"key":"cld604-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","year":"2015","journal-title":"Gut"},{"key":"cld604-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","year":"2009","journal-title":"Gastroenterology"},{"key":"cld604-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"cld604-bib-0007-20240115","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"cld604-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.dld.2014.07.008","article-title":"A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis","volume":"46","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"Suppl","key":"cld604-bib-0009-20240115","first-page":"S7","article-title":"Effects of the FXR agonist obeticholic acid on hepatic venous pressure gradient in alcoholic cirrhosis: a proof of concept phase 2A study","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"cld604-bib-0010-20240115","first-page":"PS011","article-title":"In toxic cirrhosis, the FXR agonist obeticholic acid reduces liver fibrosis indirectly via an anti\u2010inflammatory effect in liver sinusoidal endothelial cells and Kuppfer cells","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"cld604-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non\u2010cirrhotic, non\u2010alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo\u2010controlled trial","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"cld604-bib-0211-20240115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.28506","article-title":"Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"cld604-bib-0111-20240115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2015.10.007","article-title":"Statins are associated with a decreased risk of decompensation and death in veterans with hepatitis C-related compensated cirrhosis","volume":"150","year":"2016","journal-title":"Gastroenterology"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcld.604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcld.604","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01979390-201612000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T16:02:22Z","timestamp":1705334542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01979390-201612000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/cld.604","relation":{},"ISSN":["2046-2484","2046-2484"],"issn-type":[{"value":"2046-2484","type":"print"},{"value":"2046-2484","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}